LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 84.45 | 84.90 | 11071 | 8254 | 1.3412 | 1.0909 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.16 | 84.90 | 437 | 8141 | 0.0537 | 0.2826 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.16 | 84.90 | 8622 | 8141 | 1.0590 | 1.0175 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.16 | 84.90 | 797 | 8141 | 0.0979 | 0.4052 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 86.16 | 84.90 | 11301 | 8141 | 1.3880 | 1.1021 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.86 | 84.90 | 394 | 7680 | 0.0513 | 0.2664 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.86 | 84.90 | 8829 | 7680 | 1.1496 | 1.0434 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.86 | 84.90 | 620 | 7680 | 0.0807 | 0.3579 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.86 | 84.90 | 11380 | 7680 | 1.4817 | 1.1247 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 89.57 | 84.90 | 381 | 7494 | 0.0508 | 0.2615 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 89.57 | 84.90 | 9058 | 7494 | 1.2086 | 1.0595 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 89.57 | 84.90 | 651 | 7494 | 0.0869 | 0.3705 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 89.57 | 84.90 | 11643 | 7494 | 1.5535 | 1.1411 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 91.27 | 84.90 | 389 | 7420 | 0.0524 | 0.2662 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 91.27 | 84.90 | 9256 | 7420 | 1.2474 | 1.0697 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 91.27 | 84.90 | 678 | 7420 | 0.0914 | 0.3801 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 91.27 | 84.90 | 11851 | 7420 | 1.5971 | 1.1506 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.98 | 84.90 | 400 | 7257 | 0.0551 | 0.2732 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.98 | 84.90 | 9576 | 7257 | 1.3194 | 1.0883 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.98 | 84.90 | 706 | 7257 | 0.0973 | 0.3911 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 92.98 | 84.90 | 12076 | 7257 | 1.6639 | 1.1651 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 84.90 | 336 | 7000 | 0.0480 | 0.2412 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 84.90 | 9779 | 7000 | 1.3969 | 1.1078 | MN20160318_Q02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 84.90 | 602 | 7000 | 0.0860 | 0.3603 | MN20160318_Q02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 94.68 | 84.90 | 12307 | 7000 | 1.7580 | 1.1854 | MN20160318_Q02 | I17 |